(1-Methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)boronic acid, 95.0%, 10g

7-Chloro-4-hydroxy-quinoline-2-carboxylic acid, 95.0%, 10g

3-(4-fluorophenyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid, 95.0%, 500mg

4-(1,3-Dimethyl-2,3-dihydro-1H-benzimidazol-2-yl)-N,N-diphenylaniline>95.0%(HPLC)(qNMR)1g

2-Cyclopropylthiazole-4-carbaldehyde, 97%, 250mg

3-Methyl-1H-indole-5-carbonitrile, 95.0%, 1g

Plan stress-free PLPOLi 5x/0.12 IOS objective for iScope incident polarization, no cover glass correction. Working distance 15.5 mm

N-Methyl-(3-piperidin-1-yl-propyl)amine, 95.0%, 10g

5,7-dimethyl-2-(methylsulfanyl)-[1,2,4]triazolo[1,5-a]pyrimidine, 97.0%, 500mg

1-Pyridin-3-yl-cyclopentanecarboxylic acid, 95.0%, 1g

2-BROMO-5,8-DIOXASPIRO[3.4]OCTANE, 95.0%, 100mg

4,5-DIHYDRO-2-(2-METHOXYPHENYL)-4,4-DIMETHYLOXAZOLE, 95.0%, 5g

N,N-diethyl-N'-(4-fluoro-1,3-benzothiazol-2-yl)ethane-1,2-diamine, 95.0%, 500mg